🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial studies how well a dose adjusted regimen consisting of ...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2015-01-14
Trial ID
NCT02199184
This was an observational, non-interventional, real world study involving s...
Status
Completed
Location
Novartis
Start Date
2024-02-09
Trial ID
NCT06854341
The Kesimpta Pregnancy Registry is an observational, exposure cohort design...
Status
Recruiting
Location
University of California San Diego OTIS
Start Date
2023-01-05
Trial ID
NCT05634967
Treatments Being Tested
This is a non-interventional primary use of data study utilizing de-identif...
Status
Completed
Location
Novartis Investigative Site
Start Date
2022-12-08
Trial ID
NCT05090033
Treatments Being Tested
The primary goal of this study is to assess the impact of the two major dis...
Status
Completed
Location
Brigham MS Center
Start Date
2021-06-01
Trial ID
NCT05060354
Treatments Being Tested
The study aims to compare the experiences, including injection-related reac...
Status
Completed
Location
Novartis Investigative site
Start Date
2024-11-15
Trial ID
NCT06668324
In this study the investigators wish to test the hypothesis that the repert...
Status
Completed
Location
University of Southern California
Start Date
2022-01-29
Trial ID
NCT05171972
Treatments Being Tested
The DELIVER-MS study seeks to answer the question: Does early treatment wit...
Status
Active Not Recruiting
Location
University of Colorado-Anschutz Medical Campus
Start Date
2019-01-03
Trial ID
NCT03535298
Treatments Being Tested
This was a US-based, observational cross-sectional study with primary data ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2021-11-24
Trial ID
NCT05334472
Treatments Being Tested
FDA-approved multiple sclerosis (MS) disease-modifying therapies (DMTs) tar...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2018-05-02
Trial ID
NCT03500328
Treatments Being Tested